Ainos, Inc. (NASDAQ: AIMD)

Ainos, Inc. (NASDAQ: AIMD) and ugo reach new milestone in robotics with the installation of AI Nose on ugo’s humanoid service robot. 🔹 Software integration now underway, expected to complete in 2–4 weeks 🔹 Real-world AI training to follow, targeting safety, elder care, and industrial applications 🔹 Japan leads in robot production—38% of global total—with strong demand across industries 🔹 AI Nose validated in healthcare, semiconductors, and now expanding to robotics 🔹 Commercial deployment could begin as early as 2026, potentially via subscription model Smell is becoming a sixth sense for robots—AI Nose is unlocking a whole new layer of functionality. Check out Do Kim's full report and subscribe at our website to follow along! https://lnkd.in/dFPi8esN #AIMD #AI #Robotics #Ainos #ugo #AINose #SmartTech #SensorTech #Industrial #Robotics

Catch up to our new exciting milestone with this Japanese video. #AinosInc #AIMD #AINose #DigitalOlfaction #SmellID

Catch up to our new exciting milestone with this English video. #AinosInc #AIMD #AINose #DigitalOlfaction #SmellID

New milestone: Ainos and ugo株式会社 complete first robotic smell integration in Japan. We installed AI Nose module in ugo's robot and expect to begin real-world pilot shortly. This milestone ignites a new era of smell-enabled robotics. Digitizes scent into Smell ID with AI Nose. Learn more: https://lnkd.in/gARkgQ6n #AinosInc #AIMD #AINose #DigitalOlfaction #SmellID

New milestone: Ainos and ugo株式会社 complete first robotic smell integration in Japan. We installed AI Nose module in ugo's robot and expect to begin real-world pilot shortly. This milestone ignites a new era of smell-enabled robotics. Digitizes scent into Smell ID with AI Nose. Learn more: https://lnkd.in/gARkgQ6n #AinosInc #AIMD #AINose #DigitalOlfaction #SmellID

Ainos Advances VELDONA with TFDA and IRB Clearance for Two Rare Disease Trials in Taiwan We’re excited to announce a major step forward for VELDONA, our next-generation oral interferon platform. Ainos has received: ✅ TFDA approval for a Phase II trial targeting HIV-related oral warts ✅ IRB clearance for a clinical study in primary Sjögren’s Syndrome (pSS) These trials represent progress in our third strategic pillar—oral immunotherapy—alongside our AI Nose platform and AI-powered point-of-care diagnostics. Key highlights: - Targeting underserved rare diseases with limited care options - VELDONA is a non-invasive, oral alternative to injectable interferons - Prior Phase II/III studies show positive results - FDA/TFDA bridging strategy underway to accelerate market access We’re proud of our team’s execution and momentum—and excited to bring forward impactful, patient-friendly therapies. 🔗 https://lnkd.in/g6sMnRhZ #AinosInc #AIMD #VELDONA #Immunotherapy #RareDisease #Biotech #OralBiotech #MedicalInnovation #SjogrensSyndrome #HIV

🔎 Rewatch our latest Fireside Chat with Water Tower Research LLC We covered: 📌 AI Nose applications beyond healthcare 🤖 Strategic robotics + semiconductor partnerships 🧠 AI breakthroughs in digitizing smell 🏭 Smart factory + robot use cases 📈 Market scale-up opportunities across verticals 🎥 Full replay here: https://lnkd.in/g39jvydU #AinosInc #AINose #AI #Robotics #Semiconductors #DigitalHealth #SmellTech #SmallCapStocks #TechInvesting #NASDAQ #AIMD

[NEW REPORT] Water Tower Research LLC latest report recaps our deep-dive discussion on AI Nose and market expansion. AI Nose Is Scaling From Healthcare Into Robotics and Semiconductors We’re moving fast—from healthcare to automation—with real-world pilots and strategic partnerships in place. Key takeaways: • Broadening healthcare opportunities from women's health to senior care • AI Nose integrating into robots and semiconductor factories • Partnerships with Japan’s top service robot firm and the world’s largest chip packaging company • Positioned for growth in massive markets We’re not just imagining the future of scent detection —we’re building it. AI Smell is here. Digitize scent with AI Nose. Read the full report. #AIMD #AinosInc #AINose #SmellTech

Rooted in critical care, AI Nose has deep healthcare origins. From pneumonia detection to women’s health and senior care. Now adding industrial and robotic use-cases. Explore the scent digitization journey in our Fireside Chat with Water Tower Research LLC healthcare analyst Do Kim and tech analyst John Roy, Ph.D.: https://lnkd.in/g39jvydU #AinosInc #AIMD #DigitalHealth #SmellTech #MedTech #AI #SmallCapStocks